Revenue grows 7% year over year to $73.1 million as the company advances toward full-year profitability and sustained double-digit growth Evolus, reported strong financial and operational performance for the first…
Leon Medical Centers Demonstrates Strong Clinical and Operational Impact Through Advanced Fall Detection and PERS Program in Collaboration with MedSys Health Leon Medical Centers, a prominent healthcare services organization dedicated…
Cairn Surgical, Inc. Announces Pivotal Trial Success for Breast Cancer Locator System, Demonstrating Improved Surgical Outcomes Cairn Surgical, Inc., a medical technology innovator focused on improving precision in breast cancer…
Agendia Presents FLEX Study Data at ASBrS 2026 Showing Consistent MammaPrint + BluePrint Performance Across Diverse Basal-Type Breast Cancer Groups Agendia®, Inc., a recognized leader in precision oncology for breast…
Contineum Therapeutics, Inc. Reports Inducement Equity Grants Under Nasdaq Rule 5635(c)(4) Contineum Therapeutics a clinical-stage biopharmaceutical company focused on developing differentiated therapies for neuroscience, inflammation, and immunology (NI&I) indications, has…
Accendra Health to Announce First Quarter 2026 Financial Results on May 11 Accendra Health, has officially announced the date for the release of its financial results for the first quarter…
Incyte Secures U.S. Food and Drug Administration Approval for Jakafi XR Incyte has announced a significant milestone with the approval of Jakafi XR™ (ruxolitinib) extended-release tablets by the U.S. Food…
Genentech to Showcase Ophthalmology Data at ARVO 2026 Genentech is set to present a substantial body of new research highlighting the strength and breadth of its ophthalmology portfolio at the…
Centene Corporation Reports Strong First Quarter 2026 Results, Raises Full-Year Outlook Centene Corporation announced solid financial and operational performance for the first quarter of 2026, highlighted by strong earnings, disciplined…
United Therapeutics Announces Board Retirement of Prof. Raymond Dwek United Therapeutics Corporation has formally announced that Professor Raymond Dwek, C.B.E., F.R.S., will conclude his long-standing tenure as a member of…
BeOne Medicines Gains FDA Priority Review for TEVIMBRA in First-Line HER2+ Gastroesophageal Adenocarcinoma BeOne Medicines Ltd., a global oncology-focused biopharmaceutical company, has announced a major regulatory milestone in the development…
Frontier Scientific Solutions Appoints Michelle D’Angelo as Chief Commercial Officer to Drive Strategic Growth Frontier Scientific Solutions, a recognized leader in cGMP-compliant, temperature-controlled logistics, has announced the appointment of Michelle…